Gene: ZSCAN2
Official Full Name: zinc finger and SCAN domain containing 2provided by HGNC
Gene Summary: The protein encoded by this gene contains several copies of zinc finger motif, which is commonly found in transcriptional regulatory proteins. Studies in mice show that this gene is expressed during embryonic development, and specifically in the testis in adult mice, suggesting that it may play a role in regulating genes in germ cells. Alternative splicing of this gene results in several transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11890 | ZSCAN2 Knockout cell line (HeLa) | Human | ZSCAN2 | 1:3~1:6 | Negative | Online Inquiry |
KO11891 | ZSCAN2 Knockout cell line (HCT 116) | Human | ZSCAN2 | 1:2~1:4 | Negative | Online Inquiry |
KO11892 | ZSCAN2 Knockout cell line (HEK293) | Human | ZSCAN2 | 1:3~1:6 | Negative | Online Inquiry |
KO11893 | ZSCAN2 Knockout cell line (A549) | Human | ZSCAN2 | 1:3~1:4 | Negative | Online Inquiry |
ZSCAN2 Gene Knockout Cell Lines are precision-engineered cellular models designed for the comprehensive study of the ZSCAN2 gene's function and its implications in various biological processes. This genetically modified cell line is generated through CRISPR-Cas9 technology, facilitating the targeted knockout of ZSCAN2, a gene known to play a crucial role in cellular proliferation, differentiation, and response to stress stimuli. By eliminating the expression of this gene, researchers can investigate the downstream effects on cellular pathways, enabling a deeper understanding of its biological significance.
The primary mechanism underlying the functionality of ZSCAN2 Gene Knockout Cell Lines involves the disruption of ZSCAN2 expression, which in turn affects critical signaling pathways and gene regulatory networks. This cellular model allows scientists to elucidate the role of ZSCAN2 in cancer biology, immunology, and developmental biology, making it an invaluable tool in basic and applied scientific research.
In a clinical context, these cell lines hold promise for translational research, enabling the discovery of novel therapeutic targets and strategies. By identifying the pathways affected by ZSCAN2 deletion, researchers can devise innovative approaches for treating diseases where ZSCAN2 dysfunction is implicated, such as certain cancer types or autoimmune disorders.
ZSCAN2 Gene Knockout Cell Lines offer distinct advantages over alternative models, including high specificity and reliability due to precise gene editing. Unlike traditional knockdown methods, which may exhibit off-target effects or incomplete gene silencing, our knockout cell lines provide a complete loss-of-function model, delivering more definitive insights into gene functionality.
For researchers and clinicians alike, ZSCAN2 Gene Knockout Cell Lines are an essential addition to any laboratory investigating gene function and its application in disease. With our extensive experience in developing high-quality biological products, we are committed to advancing scientific discovery and facilitating breakthrough innovations in research environments.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.